Trial Profile
Assessment of the Safety and Efficacy of Ciproxan-I.V. in Daily Clinical Practice - Analysis Results From a Post-marketing Surveillance
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Aug 2012
Price :
$35
*
At a glance
- Drugs Ciprofloxacin (Primary)
- Indications Anthrax; Burn infections; Cholangitis; Cholecystitis; Peritonitis; Pneumonia; Post-traumatic infections; Sepsis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Bayer
- 30 Aug 2012 New trial record